Roguljić, H., Arambašić, J., Ninčević, V., Kuna, L., Šesto, I., Tabll, A. ... Smolić, M. (2022). The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?. Croatian medical journal, 63., 287-294. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:184:546698
Roguljić, Hrvoje, et al. "The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?." Croatian medical journal, vol. 63, 2022, str. 287-294. https://urn.nsk.hr/urn:nbn:hr:184:546698
Roguljić, Hrvoje, Jerko Arambašić, Vjera Ninčević, Lucija Kuna, Igor Šesto, Ashraf Tabll, Robert Smolić, et al. "The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?." Croatian medical journal 63 (2022): 287-294. https://urn.nsk.hr/urn:nbn:hr:184:546698
Roguljić, H., et al. (2022) 'The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?', Croatian medical journal, 63, str. 287-294. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:546698 (Datum pristupa: 02.10.2024.)
Roguljić H, Arambašić J, Ninčević V, Kuna L, Šesto I, Tabll A, i sur.. The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?. Croatian medical journal [Internet]. 2022. [pristupljeno 02.10.2024.];63:287-294. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:546698
H. Roguljić, et al., "The role of direct oral
anticoagulants in the era of
COVID-19: are antiviral therapy
and pharmacogenetics limiting
factors?", Croatian medical journal, vol. 63, str. 287-294, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:546698. [Citirano: 02.10.2024.]